Lupus Clinical Trials

A listing of Lupus medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Glendale Arizona 85306

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Phoenix Arizona 85032

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

California

UPDATED

Beverly Hills California 90211

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

La Jolla California 92037-0943

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Los Angeles California 90095-1670

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Los Angeles California 90022

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Thousand Oaks California 91360

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

Florida

UPDATED

DeBary Florida 32713

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Doral Florida 33166

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Kissimmee Florida 34741

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Tampa Florida 33612

A Phase 2 clinical study for patients with Lupus Nephritis

Georgia

UPDATED

Atlanta Georgia 30322

A Phase 2 clinical study for patients with Lupus Nephritis

Iowa

UPDATED

Des Moines Iowa 50309

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

Massachusetts

UPDATED

Boston Massachusetts 02118

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

New Jersey

UPDATED

Newark New Jersey 07103-2499

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Summit New Jersey 07901

A Phase 2 clinical study for patients with Lupus Nephritis

New York

UPDATED

Bronx New York 10457

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Bronx New York 10461

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Great Neck New York 11021

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Great Neck New York 11021

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Manhasset New York 11030

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

View More ▼

UPDATED

New York New York 10029

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

New York New York 10016

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

New York New York 10032

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Rosedale New York 11422

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

North Carolina

UPDATED

Chapel Hill North Carolina 27599-7064

A Phase 2 clinical study for patients with Lupus Nephritis

Ohio

UPDATED

Columbus Ohio 43210

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

Oklahoma

UPDATED

Oklahoma City Oklahoma 73104

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

Pennsylvania

UPDATED

Pittsburgh Pennsylvania 15261

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

Tennessee

UPDATED

Memphis Tennessee 38119

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Memphis Tennessee 38119

A Phase 2 clinical study for patients with Lupus Nephritis

Argentina

UPDATED

Buenos Aires C1015ABO

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Cordoba 5016

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

Australia

UPDATED

Adelaide 5000

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Clayton VIC 3168

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Parkville 3050

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Randwick New South Wales 2031

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Westmead 2145

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

View More ▼

UPDATED

Wolloongabba Queensland 4102

A Phase 2 clinical study for patients with Lupus Nephritis

Austria

UPDATED

Graz 8036

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Wien 1130

A Phase 2 clinical study for patients with Lupus Nephritis

Belgium

UPDATED

Brussels 1200

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Brussels 1070

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Leuven 3000

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

UPDATED

Liège B-4000

A clinical trial to evaluate treatments using Anifrolumab and Placebo for patients with Lupus Nephritis, Active Proliferative Lupus Nephritis

Canada

UPDATED

New Westminster British Columbia V3L 3W4

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Quebec G1V 4G2

A Phase 2 clinical study for patients with Lupus Nephritis

UPDATED

Toronto Ontario M5T 2S8

A Phase 2 clinical study for patients with Lupus Nephritis

Czechia

UPDATED

Hradec Kralove 50005

A Phase 2 clinical study for patients with Lupus Nephritis